George Ng
Net worth: 35 063 $ as of 30/09/2026
Net worth: 35 063 $ as of 30/09/2026
Mr. George K.
Ng is an Independent Director at TuHURA Biosciences, Inc., a Chief Executive Officer & Director at Processa Pharmaceuticals, Inc., a Chief Business Officer at IACTA Pharmaceuticals, Inc. and a Partner at Peng Life Science Ventures.
He is on the Board of Directors at TuHURA Biosciences, Inc., Processa Pharmaceuticals, Inc. and TuHURA Biosciences, Inc. (Old).
Mr. Ng was previously employed as a President, Chief Operating Officer & Director by Calidi Biotherapeutics (Nevada), Inc., a Chief Administrative & Chief Legal Officer, EVP by Sorrento Therapeutics, Inc., a Senior Vice President & General Counsel by BioDelivery Sciences International, Inc., a President by Scilex Pharmaceuticals, Inc., a Chief Compliance Officer & Head-Legal by Spectrum Pharmaceuticals, Inc., a Chief Legal Officer by Alpharma, Inc., and a President by Pan Asian Lawyers of San Diego.
He also served on the board at Calidi Biotherapeutics, Inc., Invent Medical Corp., Inflammatory Response Research, Inc., Virttu Biologics Ltd. and ImmuneOncia Therapeutics, Inc. He received his undergraduate degree from the University of California, Davis and a graduate degree from the University of Notre Dame The Law School.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2026 | 21,380 ( 0.77% ) | 35 063 $ | 30/09/2026 | |
-.--% | 26/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Chief Executive Officer | 08/08/2023 |
Peng Life Science Ventures | Founder | 01/09/2013 |
TuHURA Biosciences, Inc. (Old)
TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Director/Board Member | 01/02/2020 |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as an ophthalmic company that develops eyecare products | Founder | 01/01/2016 |
| Companies | Position | End |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | President | 23/06/2023 |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | President | 23/06/2023 |
Inflammatory Response Research, Inc.
Inflammatory Response Research, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of inflammatory disorders and conditions | Director/Board Member | 01/04/2020 |
Invent Medical Corp.
Invent Medical Corp. Medical SpecialtiesHealth Technology Develops respiratory care devices | Director/Board Member | 01/01/2020 |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Founder | 01/04/2019 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 17 |
|---|---|
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
TuHURA Biosciences, Inc. (Old)
TuHURA Biosciences, Inc. (Old) BiotechnologyHealth Technology Develops cancer vaccines and tumor microenvironment modulators | Health Technology |
Inflammatory Response Research, Inc.
Inflammatory Response Research, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of inflammatory disorders and conditions | Health Technology |
Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes non-opioid pain management products | Health Technology |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
University of Notre Dame The Law School
University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virttu Biologics Ltd.
Virttu Biologics Ltd. Pharmaceuticals: OtherHealth Technology Develops oncolytic virus therapy for treatment of cancer | Health Technology |
Pan Asian Lawyers of San Diego | |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as an ophthalmic company that develops eyecare products | Health Technology |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients | Health Technology |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Peng Life Science Ventures | |
Invent Medical Corp.
Invent Medical Corp. Medical SpecialtiesHealth Technology Develops respiratory care devices | Health Technology |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
Select your edition
All financial news and data tailored to specific country editions